Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 topical digoxin and furosemide study in actinic keratosis
NL-OMON48691Phase 2Active, not recruiting
- Sponsor
- Maruho Co., Ltd.
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of digoxin and furosemide in actinic keratosis (AK) (4 arms), sponsored by Maruho Co., Ltd. Primary endpoints: Complete clinical clearance per field, Change in AK-FAS and 6 more. Started Oct 2018; status: active, not recruiting.
02
Drugs
digoxinfurosemide
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NL-OMON48691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48691.